Hemiablative Focal Low Dose Rate Brachytherapy: A Phase II Trial Protocol

BACKGROUND: The objective of focal brachytherapy (BT) is to provide effective prostate cancer control for low-risk disease but with reduced genitourinary, gastrointestinal and sexual side effects in a cost-effective way. OBJECTIVE: The aim of this study is to describe a phase II study examining tech...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandez Ots, Ana, Bucci, Joseph, Chin, Yaw Sinn, Malouf, David, Howie, Andrew, Enari, Komiti Ese
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2016
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923592/
https://www.ncbi.nlm.nih.gov/pubmed/27296781
http://dx.doi.org/10.2196/resprot.5433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923592/
https://www.ncbi.nlm.nih.gov/pubmed/27296781
http://dx.doi.org/10.2196/resprot.5433

Ejemplares similares